MDVN

MEDIVATION, INC. Files SEC form 8-K, Other Events

moreView todays social media effects on MDVNView the latest stocks trending across Twitter. Click to view dashboardSee who Medivation is hiring next, click here to view […]

Exelixis Continues On

moreView todays social media effects on MDVNView the latest stocks trending across Twitter. Click to view dashboardSee who Medivation is hiring next, click here to view […]

4:13 pm Medivation: Astellas confirms marketing approval in Japan for XTANDI (enzalutamide) capsules, an advanced prostate cancer treatment

moreView todays social media effects on MDVNView the latest stocks trending across Twitter. Click to view dashboardSee who Medivation is hiring next, click here to view […]

ASTELLAS AND MEDIVATION SUBMIT SUPPLEMENTAL NEW DRUG APPLICATION FOR XTANDI (ENZALUTAMIDE) FOR CHEMOTHERAPY-NAÏVE ADVANCED PROSTATE CANCER

[at noodls] – TOKYO, JAPAN and SAN FRANCISCO, CA – March 18, 2014 – Astellas Pharma Inc. (TSE: 4503) and Medivation Inc. (NASDAQ: MDVN) today announced the submission of a supplemental New Drug Application (sNDA) to … moreView todays social media effects on MDVNView the latest stocks trending across Twitter. Click to view dashboardSee who Medivation is hiring next, click […]

Was Medivation’s Quarter a Disaster?

moreView todays social media effects on MDVNView the latest stocks trending across Twitter. Click to view dashboardSee who Medivation is hiring next, click here to view […]

Why Medivation (MDVN) Is Down Today

moreView todays social media effects on MDVNView the latest stocks trending across Twitter. Click to view dashboardSee who Medivation is hiring next, click here to view […]

Why Medivation, Inc. Shares Tumbled

moreView todays social media effects on MDVNView the latest stocks trending across Twitter. Click to view dashboardSee who Medivation is hiring next, click here to view […]